Grifols rejects Brookfield’s ‘undervalued’ $6.8bn bid
Private Equity Wire
NOVEMBER 20, 2024
Spanish pharmaceutical company Grifols (GRLS.MC) has rebuffed a potential takeover bid from Canadian investment firm Brookfield, arguing that the €6.45bn ($6.8bn) proposal significantly undervalues the company’s growth prospects and long-term potential, according to a report by Reuters.
Let's personalize your content